查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2046116

獸用骨移植及替代材料市場－全球產業規模、佔有率、趨勢、機會及預測：依產品、動物種類、材料、應用、最終用戶、地區及競爭格局分類，2021-2031年

Veterinary Bone Grafts and Substitutes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal Type, By Material, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸用骨移植和骨替代材料市場預計將從 2025 年的 2.7264 億美元大幅成長至 2031 年的 3.9203 億美元，複合年成長率為 6.24%。

這些特殊生物材料和合成材料對於面臨骨折、骨缺損或退化性關節疾病的動物的骨骼再生、結構支撐和修復至關重要。成長要素包括骨關節炎等整形外科疾病發病率的上升，以及「寵物人性化」這一更廣泛的趨勢，該趨勢鼓勵飼主尋求更先進的醫療護理。伴侶動物患者數量的持續成長也進一步推動了這項需求。例如，根據美國獸醫協會（AVMA）的數據，到2025年，美國犬隻數量將達到約8,730萬隻，這將直接增加需要進行整形外科手術和移植手術的動物數量。不斷成長的動物數量正在創造對這些先進獸醫解決方案的持續需求。然而，該市場面臨著一個巨大的障礙：高昂的治療費用。先進的移植材料和專業外科手術技術的總成本往往超出了許多寵物飼主的承受能力，尤其是在寵物保險覆蓋範圍有限的情況下。因此，這些經濟限制往往阻礙了高品質寵物飼主方案的選擇，從而限制了市場的進一步擴張，並將先進醫療服務的獲取主要局限於富裕的寵物主人。這種經濟障礙對這些關鍵獸醫干預措施的廣泛應用構成了重大挑戰。

市場概覽
預測期 2027-2031
市場規模：2025年 2.7264億美元
市場規模：2031年 3.9203億美元
複合年成長率：2026-2031年 6.24%
成長最快的細分市場 自體移植
最大的市場 北美洲

市場促進因素

獸醫骨移植技術和材料的顯著進步是市場擴張的主要驅動力，越來越多高效的合成材料可取代傳統的自體骨移植。創新公司正積極研發生物活性合成材料和專用植入，這些材料不僅能縮短手術時間，還能消除從患者本身獲取骨骼所帶來的併發症。業界領導者近期發布的財務報告也印證了這些先進技術的商業性成功。例如，專注於獸醫整形外科的維米安集團（Vimian Group）旗下醫療技術部門，在2025年第三季度實現了5%的收入成長，這主要得益於其先進手術解決方案的持續應用，並恢復了內部成長。同時，獸醫整形外科疾病（尤其是骨關節炎和十字韌帶損傷）的日益普遍也是推動骨移植手術需求成長的重要因素。隨著寵物年齡成長，需要手術介入的退化性關節疾病發生率激增，直接導致骨重組手術需求增加。近期保險分析也印證了這個趨勢，這些分析追蹤了此類疾病日益成長的經濟影響。根據GlobalPETS的數據顯示，Embrace寵物保險公司2024年的骨關節炎保險理賠量較前一年顯著增加49%，反映出診斷病例的大幅增加。這種不斷成長的臨床需求得益於蓬勃發展的動物醫療保健產業。例如，碩騰公司（Zoetis）公佈2025年第三季總銷售額達24億美元，凸顯了寵物醫療保健領域持續高位的支出水準。

市場挑戰

由於治療費用飆升，全球獸用骨移植材料及替代品市場面臨巨大的成長障礙。先進的骨移植手術不僅涉及昂貴的生物或合成替代品，還包括高昂的手術費、住院費以及術後護理費用。這些費用累積起來，使得許多寵物飼主難以負擔先進的整形外科手術。在許多地區，獸醫費用大多需要自付，且缺乏有效的經濟保障，這進一步加重了寵物主人的經濟負擔。能夠減輕這些高昂費用的保險選擇有限，也清楚地顯示了經濟支持的匱乏。根據北美寵物健康保險協會（NAPHIA）的數據，2024年美國寵物保險的普及率約為3.9%。這項數據表明，絕大多數寵物飼主仍然需要承擔全部醫療費用。因此，當面臨需要植骨的昂貴整形外科手術時，許多馬主被迫選擇成本較低的保守治療，這直接限制了市場的獲利能力和整體滲透率。

市場趨勢

骨移植與骨科生技藥品和幹細胞療法的融合正在深刻地改變獸醫市場，將治療模式從「被動結構修復」轉變為「主動生物再生」。這一趨勢包括將間質幹細胞和生長因子等先進生技藥品整合到傳統移植材料中，以增強骨誘導並改善骨關節炎等複雜整形外科疾病的治療效果。業界正大力投資於這些「現成」的再生醫學解決方案，旨在提供即時且擴充性的治療方案，避免自體移植帶來的併發症。例如，2025年6月，Gallant Therapeutics公司獲得了1,800萬美元的B輪資金籌措，用於其即用型同種異體幹細胞療法的商業化，顯示市場對下一代再生醫學產品充滿信心。同時，將3D列印技術應用於患者特異性骨支架的製備，正在為獸醫重組手術樹立精準度的新標竿。這項技術能夠製造出完美貼合動物骨缺損獨特解剖形狀的植入，從而顯著縮短手術時間並提高機械穩定性。積層製造技術的應用正在迅速擴展，已從學術原型階段發展到能夠提供客製化解決方案且交貨週期短的工業級生產設施。例如，Wimba公司於2025年2月推出了新的內部3D列印設施，以擴大其生產患者專用獸用整形外科器械的能力，從而直接滿足日益成長的客製化手術需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸用骨移植及替代市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（自體移植、同種異體移植、異質骨移植、其他）
    • 動物種類（狗、貓、馬、其他）
    • 依材料分類（磷酸三鈣（TCP）、陶瓷、生物玻璃、其他）
    • 依應用領域（整形外科、牙科、眼科、骨癌、其他）
    • 依最終使用者（獸醫院/診所、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸用骨移植及替代市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲獸用骨移植及替代市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區獸用骨移植及替代品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲獸用骨移植及替代品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲獸用骨移植及替代品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球獸用骨移植及替代材料市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Vimian Group AB
  • TheraVet SA
  • Biomendex Oy
  • Integra LifeSciences Corporation
  • Progenica Therapeutics, LLC
  • Nutramax Laboratories Veterinary Sciences, Inc.
  • RITA LEIBINGER GmbH & Co. KG
  • AlphaLogix, LLC
  • VETEREGEN
  • BioChange

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27375

The Global Veterinary Bone Grafts and Substitutes Market is projected to expand significantly, rising from USD 272.64 Million in 2025 to USD 392.03 Million by 2031, demonstrating a 6.24% Compound Annual Growth Rate. These specialized biological or synthetic materials are crucial for bone regeneration, structural support, and repair in animals facing fractures, osseous defects, or degenerative joint conditions. Key growth drivers include the increasing incidence of orthopedic issues such as osteoarthritis and the prevalent trend of pet humanization, which encourages owners to seek advanced medical care. This demand is further boosted by a steadily growing companion animal patient base; for instance, the United States dog population reached approximately 87.3 million in 2025, according to the American Veterinary Medical Association, directly increasing the number of potential candidates for orthopedic surgeries and grafting procedures. This rising population creates a sustained need for these advanced veterinary solutions. However, the market encounters a significant hurdle in the form of high treatment expenses. The combined costs of advanced graft materials and specialized surgical expertise frequently exceed what many pet owners can afford, particularly in scenarios where pet insurance coverage remains limited. Consequently, these financial limitations often deter the selection of premium grafting options, thereby impeding broader market expansion and restricting access to advanced care primarily to more affluent segments of pet ownership. This economic barrier poses a substantial challenge to the widespread adoption of these crucial veterinary interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 272.64 MIllion
Market Size 2031USD 392.03 MIllion
CAGR 2026-20316.24%
Fastest Growing SegmentAutografts
Largest MarketNorth America

Market Driver

Significant advancements in veterinary bone graft technologies and materials are a primary catalyst for market expansion, increasingly providing more effective synthetic alternatives to traditional autografts. Innovators are actively developing bioactive synthetic substitutes and specialized implants that not only reduce surgical time but also eliminate the morbidity associated with harvesting bone from the patient's own body. The commercial success of these sophisticated technologies is underscored by recent financial reports from leading industry players; for example, Vimian Group's MedTech segment, specializing in veterinary orthopedics, returned to organic growth with a 5% increase in the third quarter of 2025, driven by the sustained adoption of its advanced surgical solutions. Concurrently, the increasing prevalence of veterinary orthopedic disorders, particularly osteoarthritis and cruciate ligament injuries, acts as another critical accelerator for the demand for grafting procedures. As the companion animal population ages, the frequency of degenerative joint diseases requiring surgical intervention has escalated, directly increasing the volume of necessary bone reconstruction surgeries. This trend is further supported by recent insurance analyses, which track the growing financial impact of these conditions. According to GlobalPETS, data from Embrace Pet Insurance revealed a significant 49% year-over-year increase in osteoarthritis claims in 2024, reflecting a substantial rise in diagnosed cases. This expanding clinical need is bolstered by a robust animal health economy, as evidenced by Zoetis reporting total revenue of $2.4 billion for the third quarter of 2025, highlighting the consistent high expenditure on companion animal care.

Market Challenge

The Global Veterinary Bone Grafts and Substitutes Market faces a substantial impediment to growth due to the elevated cost of treatment. Advanced bone grafting procedures encompass not only the price of sophisticated biological or synthetic substitutes but also significant surgical fees, hospitalization, and subsequent post-operative care. These cumulative expenses frequently position premium orthopedic interventions beyond the financial reach of a considerable proportion of pet owners. The economic burden is exacerbated by the fact that veterinary healthcare in many regions is primarily an out-of-pocket expense, with very limited financial safety nets available to mitigate these costs. This scarcity of financial support is clearly demonstrated by the limited adoption of coverage options that could otherwise alleviate these high expenses. According to the North American Pet Health Insurance Association, the pet insurance penetration rate in the United States was approximately 3.9% in 2024. This statistic indicates that the vast majority of pet owners remain financially vulnerable to the full cost of medical procedures. Consequently, when confronted with expensive orthopedic surgeries requiring bone grafts, many owners are compelled to opt for less costly, conservative management strategies, thereby directly limiting the market's revenue potential and overall adoption rate.

Market Trends

The convergence of bone grafts with orthobiologics and stem cell therapies is profoundly transforming the veterinary market, shifting treatment paradigms from passive structural repair to active biological regeneration. This trend involves integrating traditional graft materials with advanced biologics, such as mesenchymal stem cells and growth factors, to accelerate osteoinduction and improve outcomes in complex orthopedic conditions like osteoarthritis. The industry is witnessing significant investment in these "off-the-shelf" regenerative solutions, which aim to provide immediate, scalable therapeutic options without the morbidity associated with autograft harvesting. For example, Gallant Therapeutics secured $18 million in Series B financing in June 2025 to commercialize its ready-to-use allogeneic stem cell therapies, validating strong market confidence in next-generation regenerative products. Simultaneously, the integration of 3D-printing technology for patient-specific bone scaffolds is establishing a new benchmark for precision in veterinary reconstructive surgery. This technology enables the fabrication of implants that perfectly conform to the unique anatomical geometry of an animal's osseous defect, substantially reducing surgical time and enhancing mechanical stability. The adoption of additive manufacturing is rapidly scaling, progressing beyond academic prototypes to industrial-grade production facilities capable of delivering customized solutions with short lead times. As an illustration, Wimba launched a new in-house 3D printing facility in February 2025 to expand its capacity for manufacturing patient-specific veterinary orthopedic devices, directly addressing the growing demand for tailored surgical interventions.

Key Market Players

  • Vimian Group AB
  • TheraVet S.A.
  • Biomendex Oy
  • Integra LifeSciences Corporation
  • Progenica Therapeutics, LLC
  • Nutramax Laboratories Veterinary Sciences, Inc.
  • RITA LEIBINGER GmbH & Co. KG
  • AlphaLogix, LLC
  • VETEREGEN
  • BioChange

Report Scope

In this report, the Global Veterinary Bone Grafts and Substitutes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Bone Grafts and Substitutes Market, By Product

  • Autografts
  • Allografts
  • Xenografts
  • Others

Veterinary Bone Grafts and Substitutes Market, By Animal Type

  • Dogs
  • Cats
  • Horses
  • Others

Veterinary Bone Grafts and Substitutes Market, By Material

  • Tricalcium Phosphate (TCP)
  • Ceramic
  • Bioglass
  • Others

Veterinary Bone Grafts and Substitutes Market, By Application

  • Orthopedics
  • Dental
  • Ocular
  • Osteosarcoma
  • Others

Veterinary Bone Grafts and Substitutes Market, By End User

  • Veterinary Hospitals & Clinics
  • Others

Veterinary Bone Grafts and Substitutes Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Bone Grafts and Substitutes Market.

Available Customizations:

Global Veterinary Bone Grafts and Substitutes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Bone Grafts and Substitutes Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Autografts, Allografts, Xenografts, Others)
    • 5.2.2. By Animal Type (Dogs, Cats, Horses, Others)
    • 5.2.3. By Material (Tricalcium Phosphate (TCP), Ceramic, Bioglass, Others)
    • 5.2.4. By Application (Orthopedics, Dental, Ocular, Osteosarcoma, Others)
    • 5.2.5. By End User (Veterinary Hospitals & Clinics, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Veterinary Bone Grafts and Substitutes Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Animal Type
    • 6.2.3. By Material
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Bone Grafts and Substitutes Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Animal Type
        • 6.3.1.2.3. By Material
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Veterinary Bone Grafts and Substitutes Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Animal Type
        • 6.3.2.2.3. By Material
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Veterinary Bone Grafts and Substitutes Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Animal Type
        • 6.3.3.2.3. By Material
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Veterinary Bone Grafts and Substitutes Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Animal Type
    • 7.2.3. By Material
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Bone Grafts and Substitutes Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Animal Type
        • 7.3.1.2.3. By Material
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. France Veterinary Bone Grafts and Substitutes Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Animal Type
        • 7.3.2.2.3. By Material
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Veterinary Bone Grafts and Substitutes Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Animal Type
        • 7.3.3.2.3. By Material
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Veterinary Bone Grafts and Substitutes Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Animal Type
        • 7.3.4.2.3. By Material
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Veterinary Bone Grafts and Substitutes Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Animal Type
        • 7.3.5.2.3. By Material
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia Pacific Veterinary Bone Grafts and Substitutes Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Animal Type
    • 8.2.3. By Material
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Veterinary Bone Grafts and Substitutes Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Animal Type
        • 8.3.1.2.3. By Material
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Veterinary Bone Grafts and Substitutes Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Animal Type
        • 8.3.2.2.3. By Material
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Veterinary Bone Grafts and Substitutes Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By Material
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Veterinary Bone Grafts and Substitutes Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Animal Type
        • 8.3.4.2.3. By Material
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Veterinary Bone Grafts and Substitutes Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Animal Type
        • 8.3.5.2.3. By Material
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Middle East & Africa Veterinary Bone Grafts and Substitutes Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Animal Type
    • 9.2.3. By Material
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Veterinary Bone Grafts and Substitutes Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Animal Type
        • 9.3.1.2.3. By Material
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Veterinary Bone Grafts and Substitutes Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Animal Type
        • 9.3.2.2.3. By Material
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Veterinary Bone Grafts and Substitutes Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Animal Type
        • 9.3.3.2.3. By Material
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Veterinary Bone Grafts and Substitutes Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Animal Type
    • 10.2.3. By Material
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Bone Grafts and Substitutes Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Animal Type
        • 10.3.1.2.3. By Material
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Veterinary Bone Grafts and Substitutes Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Animal Type
        • 10.3.2.2.3. By Material
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Veterinary Bone Grafts and Substitutes Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Animal Type
        • 10.3.3.2.3. By Material
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Veterinary Bone Grafts and Substitutes Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Vimian Group AB
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. TheraVet S.A.
  • 15.3. Biomendex Oy
  • 15.4. Integra LifeSciences Corporation
  • 15.5. Progenica Therapeutics, LLC
  • 15.6. Nutramax Laboratories Veterinary Sciences, Inc.
  • 15.7. RITA LEIBINGER GmbH & Co. KG
  • 15.8. AlphaLogix, LLC
  • 15.9. VETEREGEN
  • 15.10. BioChange

16. Strategic Recommendations

17. About Us & Disclaimer